- Approval Id
- 23c4306667e04191
- Drug Name
- CLAMOVID GRANULES 156.25 mg/5 ml
- Product Name
- CLAMOVID GRANULES 156.25 mg/5 ml
- Approval Number
- SIN12027P
- Approval Date
- 2002-07-17
- Registrant
- GOLDPLUS UNIVERSAL PTE LTD
- Licence Holder
- GOLDPLUS UNIVERSAL PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- GRANULE, FOR SUSPENSION
- Dosage
- **Dosage and Administration**
_**CLAMOVID 625 TABLET**_
**Adults and Children Over 12 years old:**
Severe infections:Oral, one tablet, three times a day.Other infections:Oral, one tablet, two times a day.
_**Dosage in Renal Impairment:**_
Adults:Mild impairment (Creatinine clearance > 30ml/min):
No change in dosage.:Moderate impairment (Creatinine clearance 10–30 ml/min):
One tablet, 12 hourly.:Severe impairment (Creatinine clearance < 10ml/min):
Not recommended.
_**Dosage in Hepatic Impairment:**_
Dose with caution; monitor hepatic function at regular intervals.
There are, as yet, insufficient data on which to base a dosage recommendation.
Note: Not recommended in children of 12 years and under.
_**CLAMOVID GRANULES**_
The usual recommended daily dosage is 25 mg/Kg/day in divided doses every 8 hours. In more serious infections the dosage may be increased up to 50 mg/Kg/day in divided doses every eight hours.
Children:
1 to 6 years (10 to 18kg):Oral, 5ml (approximately 125mg of Amoxycillin and 31.25mg of Clavulanic Acid every eight hour.7 to 12 hours (18 to 40kg):Oral, 10ml (approximately 250mg of Amoxycillin and 62.5mg of Clavulanic Acid) every eight hours.
_**Duration of therapy should be appropriate to the indication and should not exceed 14 days without review.**_
- Route Of Administration
- ORAL
- Indication Info
- **Indications**
For treatment of acute otitis media, sinusitis, pneumonia, skin and soft tissue infections, urinary tract infections caused by betalactamase-producing strains of bacteria.
- Contraindications
- **Contraindications**
- Contraindicated in patients known to be hypersensitive to penicillin. Attention should be paid to possible cross-sensitivity with other beta-lactam antibiotics e.g. cephalosporins.
- Contraindicated in patients with a previous history of penicillin-associated jaundice/hepatic dysfunction
- Contraindicated in patients with infectious mononucleosis
- Atc Code
- J01CR02
- Atc Item Name
- amoxicillin and beta-lactamase inhibitor
- Pharma Manufacturer Name
- GOLDPLUS UNIVERSAL PTE LTD
- Company Detail Path
- /organization/goldplus-universal-pte-ltd
